MIA, a novel serum marker for progression of malignant melanoma.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Anticancer Research

• Publication date

  1999-07-01

• Fields of study

  Medicine

• Identifiers
  PMID 10470221
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mouse CD‐RAP/MIA gene: Structure, chromosomal localization, and expression in cartilage and chondrosarcoma

  1997cited by this paper
• Melanoma-inhibiting activity, a novel serum marker for progression of malignant melanoma.

  1997cited by this paper
• Structure and Promoter Analysis of the Gene Encoding the Human Melanoma-inhibiting Protein MIA (*)

  1996cited by this paper
• Assignment of the human melanoma inhibitory activity gene (MIA) to 19q13.32-q13.33 by fluorescence in situ hybridization (FISH).

  1996cited by this paper
• Cloning of a novel malignant melanoma-derived growth-regulatory protein, MIA.

  1994cited by this paper

• Plasma MIA, CRP, and Albumin Predict Cognitive Decline in Parkinson's Disease

  2022cites this paper
• Plasma MIA, CRP, and albumin predict cognitive decline in Parkinson’s Disease 3

  2022cites this paper
• Blood Biomarkers of Uveal Melanoma: Current Perspectives

  2020cites this paper
• Adaptor proteins: Flexible and dynamic modulators of immune cell signalling

  2020cites this paper
• Blood Biomarkers of Uveal Melanoma: Current Perspectives

  2020cites this paper
• Melanoma inhibitory activity in melanoma diagnostics and therapy – a small protein is looming large

  2014cites this paper
• Diagnostic and Prognostic Biomarkers in Cutaneous Melanoma

  2014cites this paper
• Clinical, pathologic, and imaging features and biological markers of uveal melanoma.

  2014cites this paper
• Molecular Diagnostics for Melanoma

  2014cites this paper
• Potential biomarkers for malignant melanoma

  2013cites this paper
• Identification of IGPR-1 as a novel adhesion molecule involved in angiogenesis

  2012cites this paper
• Gene targeting in melanoma therapy: exploiting of surface markers and specific promoters

  2012cites this paper
• Melanoma: Surface markers as the first point of targeted delivery of therapeutic genes in multilevel gene therapy

  2011cites this paper
• Biomarkers for Melanoma Diagnosis and the Technologies Used to Identify Them

  2011cites this paper
• Melanoma biomarkers: Vox clamantis in deserto (Review).

  2010cites this paper
• Serum markers of cutaneous melanoma.

  2010cites this paper
• Migration-associated secretion of melanoma inhibitory activity at the cell rear is supported by KCa3.1 potassium channels

  2010cites this paper
• Abstract. Detecting malignant melanoma at an early stage, monitoring therapy, predicting recurrence and identifying patients at risk for metastasis continue to be a challenging and demanding objective. The last two decades have witnessed inno-

  2010cites this paper
• Tumors of Melanocytes

  2008cites this paper
• Gene expression profile analysis of pituitary adenomas developed by HMGA transgenic mice ”

  2007cites this paper
• International Doctorate Program in Molecular Oncology and Endocrinology Doctorate School in Molecular Medicine

  2007cites this paper
• Genomic tests for ovarian cancer detection and management.

  2006cites this paper
• Inhibition of immunosuppressive effects of melanoma‐inhibiting activity (MIA) by antisense techniques

  2005cites this paper
• Melanoma Inhibitory Activity (MIA) increases the invasiveness of pancreatic cancer cells

  2005cites this paper
• Elevated MIA levels in the serum of pregnant women and of children

  2004cites this paper
• Ultraviolet radiation induces release of MIA: a new mechanism for UVR-induced progression of melanoma.

  2004cites this paper
• Recombinant Expression of Functional Active MIA (Melanoma Inhibitory Activity) Protein for Mutation Analysis Using the RTS System

  2003cites this paper
• Backbone dynamics of the human MIA protein studied by 15N NMR relaxation: Implications for extended interactions of SH3 domains

  2003cites this paper
• Establishing the protein MIA (melanoma inhibitory activity) as a marker for chondrocyte differentiation.

  2003cites this paper
• Biomarkers in melanoma: staging, prognosis and detection of early metastases

  2003cites this paper
• Melanoma inhibitory activity: a novel serum marker for uveal melanoma

  2002cites this paper
• Clinical significance of 5-S-cysteinyldopa monitoring in patients with malignant melanoma.

  2002cites this paper
• Cloning and characterization of the expression pattern of a novel splice product MIA (splice) of malignant melanoma-derived growth-inhibiting activity (MIAY CD-RAP)

  2002cites this paper
• Elevated MIA serum levels are predictors of poor prognosis after surgical resection of metastatic malignant melanoma.

  2002cites this paper
• Mia: Ein Tumormarker für das Maligne Melanom

  2002cites this paper
• Melanoma-inhibiting activity (MIA/CD-RAP) is expressed in a variety of malignant tumors of mainly neuroectodermal origin.

  2002cites this paper
• Cloning and characterization of the expression pattern of a novel splice product MIA (splice) of malignant melanoma-derived growth-inhibiting activity (MIA/CD-RAP) [corrected].

  2002cites this paper
• Using a continuous transformation of the Breslow thickness for prognosis in cutaneous melanoma.

  2001cites this paper
• Identification and characterization of an inner ear-expressed human melanoma inhibitory activity (MIA)-like gene (MIAL) with a frequent polymorphism that abolishes translation.

  2001cites this paper
• Cysteine and indole derivatives as markers for malignant melanoma.

  2001cites this paper
• Elevated MIA serum levels are of relevance for management of metastasized malignant melanomas: results of a German multicenter study.

  2000cites this paper
• Serum concentration of 5‐S‐cysteinyldopa in patients with melanoma

  2000cites this paper
• Comparative study on the clinical use of protein S-100B and MIA (melanoma inhibitory activity) in melanoma patients.

  2000cites this paper
• Letter to the Editor: Sequence-specific 1H, 13C, and 15N assignment of the human melanoma inhibitory activity (MIA) protein

  2000cites this paper
• Einfluß von MIA auf die Lebermetastasierung von A-mel 3 Melanomzellen

  1999cites this paper
• In situ expression patterns of melanoma‐inhibiting activity (MIA) in melanomas and breast cancers

  1999cites this paper
• MIA („melanoma inhibitory activity”) Biologische Funktionen und klinische Relevanz beim malignen Melanom

  1998cites this paper
• National Academy of Clinical Biochemistry Guidelines for the Use of Tumor Markers in Malignant Melanoma

  year unknowncites this paper